Endo Int'l (ENDP) Tops Q1 EPS by 11c; Boosts FY15 EPS Outlook
Get Alerts ENDP Hot Sheet
Price: $0.29 --0%
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
MAXN, CSTR, ACU, More
Financial Fact:
Net pharmaceutical product sales: 422.03M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Endo Int'l (NASDAQ: ENDP) reported Q1 EPS of $1.17, $0.11 better than the analyst estimate of $1.06. Revenue for the quarter came in at $714 million versus the consensus estimate of $714.42 million.
Endo Int'l sees FY2015 EPS of $4.40 - $4.60, versus prior guidance of $4.35 - $4.55 and the consensus of $4.48. Endo Int'l sees FY2015 revenue of $2.90 - $3.00 billion, versus the consensus of $2.99 billion.
For earnings history and earnings-related data on Endo Int'l (ENDP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
- Growth isn't weak enough to truly undercut inflation pressures - BMO
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!